Douglass Winthrop Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$396K Hold
1,025
0.01% 251
2026
Q1
$300K Sell
1,025
-100
-9% -$32.9K 0.01% 262
2025
Q4
$394K Sell
1,125
-17
-1% -$5.75K 0.01% 244
2025
Q3
$369K Buy
1,142
+17
+2% +$5.29K 0.01% 239
2025
Q2
$438K Sell
1,125
-337
-23% -$136K 0.01% 197
2025
Q1
$636K Sell
1,462
-50
-3% -$20.1K 0.01% 172
2024
Q4
$558K Hold
1,512
0.01% 199
2024
Q3
$786K Hold
1,512
0.02% 166
2024
Q2
$819K Hold
1,512
0.02% 148
2024
Q1
$784K Buy
1,512
+187
+14% +$93K 0.02% 154
2023
Q4
$625K Hold
1,325
0.01% 157
2023
Q3
$577K Hold
1,325
0.01% 152
2023
Q2
$589K Hold
1,325
0.01% 160
2023
Q1
$609K Sell
1,325
-36
-3% -$17.1K 0.02% 153
2022
Q4
$698K Hold
1,361
0.02% 143
2022
Q3
$618K Hold
1,361
0.02% 142
2022
Q2
$657K Hold
1,361
0.02% 149
2022
Q1
$669K Sell
1,361
-114
-8% -$52.1K 0.02% 165
2021
Q4
$684K Hold
1,475
0.02% 167
2021
Q3
$550K Sell
1,475
-26
-2% -$9.88K 0.01% 186
2021
Q2
$573K Buy
1,501
+226
+18% +$86.4K 0.01% 185
2021
Q1
$458K Hold
1,275
0.01% 197
2020
Q4
$409K Hold
1,275
0.01% 207
2020
Q3
$342K Hold
1,275
0.01% 212
2020
Q2
$335K Buy
+1,275
New +$340K 0.01% 202

Other funds holding ELV

Douglass Winthrop Advisors's ELV Position: Q2 2026 in Review

Douglass Winthrop Advisors held its Elevance Health (ELV) position steady in Q2 2026 at 1,025 shares worth $396K. The position accounts for 0.01% of the portfolio, ranked #251.

Douglass Winthrop Advisors first reported a position in ELV in Q2 2020 and has held it in 25 quarters since. The position peaked at $819K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Douglass Winthrop Advisors held 1,025 shares of Elevance Health worth $396K as of Q2 2026.
  • Douglass Winthrop Advisors left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.01% of Douglass Winthrop Advisors's portfolio in Q2 2026, its #251 holding.
  • Douglass Winthrop Advisors first reported a position in Elevance Health in Q2 2020 and has held it in 25 quarters since.
  • Douglass Winthrop Advisors's Elevance Health position peaked at $819K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Douglass Winthrop Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.